Development of prognosis and diagnosis model for osteosarcoma based on oxidative stress-related genes

The most frequently malignant bone tumor in children and teenagers is osteosarcoma. However, it is unclear how oxidative stress (OS) affects osteosarcoma. The purpose of this investigation was to determine how OS genes affected osteosarcoma development and prognosis. The Therapeutically Applicable Research to Generate Effective Treatments (TARGET), GenotypeTissue Expression (GTEx), and Gene Expression Omnibus (GEO) databases were used to obtain sample gene expression profiles and clinical data for this investigation. Based on distinct OS gene expression patterns, nonnegative matrix factorization (NMF) clustering was performed to identify molecular groupings. A multivariate Cox regression analysis was used to build the prognostic model. More thorough estimate of immune cells in malignant tumor tissues and prediction of treatment response. Functional analyses include Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses, and Gene Set Variation Analysis (GSVA). An in-vitro investigation of OD, a Chinese medication, has been substantial. Using network pharmacology to research the possible therapeutic targets and molecular processes of Oldenlandia diffusa (OD) in the treatment of osteosarcoma, basing on high - and low-risk prognostic risk groups. The diagnostic models were built using multilayer perceptron (MLP) neural networks. To predict the survival of patients with osteosarcoma, a prognostic model and a nomogram were created. OS-related genes were shown to be closely linked to the immune state and predictive survival of osteosarcoma patients, according to the GSVA and Gene functional enrichment analyses. 7 active ingredients and 233 target genes were identified from OD, and 25 of the target genes intersected with osteosarcoma-related genes were thought to be prospective therapeutic targets. Network pharmacological analysis showed that the active ingredients for the treatment of osteosarcoma was closely connected with regulation of immune cells. The diagnostic models were constructed based on a 9-gene signature showing excellent recognition ability of osteosarcoma patients. The interplay between OS-related genes and immunology in the development of osteosarcoma might generate new insights into molecular processes and targeted therapeutics for patients with the disease.